
The cofounder and chief executive officer of NKILT Therapeutics discussed unique advantages of the CIR platform.
The cofounder and chief executive officer of NKILT Therapeutics discussed unique advantages of the CIR platform.
The cofounder and chief executive officer of NKILT Therapeutics discussed new preclinical data presented at WOCTC.
Raphaël G. Ognar, chief executive officer and co-founder of NKILT Therapeutics, discussed approaches to help increase patient access to cell therapies.
Published: August 16th 2024 | Updated: August 19th 2024
Published: March 18th 2024 | Updated: June 3rd 2024
Published: December 7th 2024 | Updated:
Published: December 12th 2022 | Updated:
Published: July 14th 2024 | Updated:
Published: May 18th 2023 | Updated: